Profiles
- 1 results
Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial
- Ildiko Lingvay (Lead / Corresponding author)
- , Andrei-Mircea Catarig
- , Juan P. Frias
- , Harish Kumar
- , Nanna L. Lausvig
- , Carel W. le Roux
- , Desirée Thielke
- , Adie Viljoen
- , Rory McCrimmon
Research output: Contribution to journal › Article › peer-review
247
Link opens in a new tab
Citations
(Scopus)
3019
Downloads
(Pure)